Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Ekso Bionics Holdings, Inc. (EKSO) had Revenue of $17.93M for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$17.93M
Net Income	$-11.33M
Cost of Goods Sold	$8.41M
Gross Profit	$9.51M
Operating Expenses	$28.39M
Operating Income	$-10.46M
Non-Operating Income/Expense	$-0.87M
Pre-Tax Income	$-11.33M
Normalized Pre-Tax Income	$-11.33M
Income after Taxes	$-11.33M
Income from Continuous Operations	$-11.33M
Consolidated Net Income/Loss	$-11.33M
Normalized Income after Taxes	$-11.33M
EBIT	$-10.46M
EBITDA	$-8.85M
Weighted-Average Shares Outstanding (Basic)	20.16M
Weighted-Average Shares Outstanding (Diluted)	20.16M
Earnings per Share (EPS) (Basic)	$-0.56
Earnings per Share (EPS) (Diluted)	$-0.56
Balance Sheet Financials
Current Assets	$18.84M
Property, Plant, and Equipment	$1.58M
Long-Term Assets	$7.81M
Total Assets	$26.65M
Current Liabilities	$7.54M
Long-Term Debt	$3.85M
Long-Term Liabilities	$6.41M
Total Liabilities	$13.95M
Common Equity	$12.71M
Tangible Shareholders Equity	$7.70M
Shareholders Equity	$12.71M
Common Shares Outstanding	22.20M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-9.85M
Cash Flow from Investing Activities	$-0.04M
Cash Flow from Financial Activities	$7.77M
Beginning Cash	$8.64M
End Cash	$6.49M
Increase/Decrease in Cash	$-2.15M
Stock-Based Compensation	$1.37M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.50
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.23
Debt to Equity Ratio	0.40
Gross Margin	53.06%
Operating Margin	-58.35%
EBIT Margin	-58.35%
EBITDA Margin	-49.38%
Pre-Tax Profit Margin	-63.21%
Profit Margin	-63.21%
Free Cash Flow	$-9.85M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.67
Inventory Turnover	1.84
Receiveable Turnover	2.48
Days Sales in Receivables	147.38
Return on Equity	-89.16%
Return on Tangible Equity	-147.22%
Return on Assets	-42.51%
Return on Investments	-68.41%
Book Value Per Share	$0.57
Free Cash Flow per Share	$-0.49
Operating Cash Flow per Share	$-0.49

Data from Zacks Investment Research, Inc.